作者: Biqin Li , Margaretha H. M. Bakker , Dawn M. George , Anil Vasudevan , Melissa J. Michmerhuizen
DOI:
关键词:
摘要: The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein A, R 1 , 2 3 and m, are defined in the description. also methods making said compounds, compositions containing which useful for inhibiting kinases such as Glycogen Synthase kinase (GSK-3), Rho (ROCK), Janus Kinases (JAK), Cdc7, AKT, PAK4, PLK, CK2, KDR, MK2, JNK1, aurora, pim nek 2.